Surgical Procedure, UnspecifiedNCT06638073
Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC
An observational study of Surgical Procedure, Unspecified and Intensive Care Units (ICUs), run by Medtronic - MITG at 1 site in Canada.
Trial summary
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - in hospital and at-home, in patients undergoing non-cardiac surgery. Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- Surgical Procedure, Unspecified, Intensive Care Units (ICUs)
- How many people
- 50 participants
- Where
- 1 siteCanada
- Study dates
- 13 Mar 2025to 30 Jul 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients that have undergone a non-cardiac surgery requiring an inpatient hospital stay and peri-op patients who are in the Surgical High Acuity Unit (SHAU) at SPH.
Who may be able to join
- 19 years or older
- Patients that have undergone a non-cardiac surgery at SPH requiring an inpatient hospital stay
- Peri-op patients who are in the Surgical High Acuity Unit (SHAU) and those followed by Anesthesia Perioperative Outreach team on the ward
- Living within British Columbia, Canada and in an area that is covered by Bell cellular network
Who cannot join
- Patient refusal
- Lack of capacity to consent to the study (including having received sedative or general anesthetic within the past 24 hours)
- Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
- Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
- No access to cell phone nor landline at home to receive follow-ups
- Preoperatively known to be discharged to a nursing home or rehabilitation facility
- Known allergic reactions to any part material of study devices
Trial locations and contacts
1 site in 1 country.
About this study
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - in hospital and at-home, in patients undergoing non-cardiac surgery.
What is being measured
The primary outcome is the main question the study is designed to answer.
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.
Measured: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed by ensuring clinical workflow is met when using the monitoring platform.
Measured: From enrollment to the end of follow up at 10 days
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed via an assessment of the Usability questionnaires.
Measured: From enrollment to the end of follow up at 10 days
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed by an evaluation of potential harm, adverse events and safety issues.
Measured: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed via an assessment of the data flow: does the correct patient vitals information reach the clinicians at the right time?
Measured: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed by determining if the CCPC platform provided a holistic view of each patient with vitals, medication, and other collected data.
Measured: From enrollment to the end of follow up at 10 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Oct 2024
- Study start13 Mar 2025
- Primary completion30 Jul 2026
- Study completion30 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Surgical Procedure, UnspecifiedStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Medtronic - MITG
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Excelar, Cloud DX Inc., Bridge Health Solutions, Providence Healthcare
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06638073
- Sponsor's protocol ID
- H24-00862
- Status last verified
- Oct 2026
- First submitted
- 16 Sep 2024
- Last updated
- 15 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC
- ClinicalTrials.gov ID
- NCT06638073
- Acronym / sponsor ID
- H24-00862
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Medtronic - MITGIndustry (pharma, biotech, devices)
- Collaborators
- Excelar, Cloud DX Inc., Bridge Health Solutions, Providence Healthcare
- Study start
- 13 Mar 2025 (actual)
- Primary completion
- 30 Jul 2026 (actual)
- Study completion
- 30 Jul 2027 (estimated)
- First posted
- 15 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - in hospital and at-home, in patients undergoing non-cardiac surgery.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients that have undergone a non-cardiac surgery requiring an inpatient hospital stay and peri-op patients who are in the Surgical High Acuity Unit (SHAU) at SPH.
Key inclusion criteria (4 listed)
- 19 years or older
- Patients that have undergone a non-cardiac surgery at SPH requiring an inpatient hospital stay
- Peri-op patients who are in the Surgical High Acuity Unit (SHAU) and those followed by Anesthesia Perioperative Outreach team on the ward
- Living within British Columbia, Canada and in an area that is covered by Bell cellular network
Key exclusion criteria (7 listed)
- Patient refusal
- Lack of capacity to consent to the study (including having received sedative or general anesthetic within the past 24 hours)
- Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
- Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
- No access to cell phone nor landline at home to receive follow-ups
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Collect patient and clinicians' feedback about the CCPC Platform
Time frame: From enrollment to the end of follow up at 10 days
This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.
Confirm the technical goals of the CCPC platform are met.
Time frame: From enrollment to the end of follow up at 10 days
This will be completed by ensuring clinical workflow is met when using the monitoring platform.
Collect patient and clinicians' feedback about the CCPC Platform
Time frame: From enrollment to the end of follow up at 10 days
This will be completed via an assessment of the Usability questionnaires.
Collect patient and clinicians' feedback about the CCPC Platform
Time frame: From enrollment to the end of follow up at 10 days
This will be completed by an evaluation of potential harm, adverse events and safety issues.
Confirm the technical goals of the CCPC platform are met.
Time frame: From enrollment to the end of follow up at 10 days
This will be completed via an assessment of the data flow: does the correct patient vitals information reach the clinicians at the right time?
Confirm the technical goals of the CCPC platform are met.
Time frame: From enrollment to the end of follow up at 10 days
This will be completed by determining if the CCPC platform provided a holistic view of each patient with vitals, medication, and other collected data.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Surgical Procedure, Unspecified
Recruiting
Improving Surgical Communication for Patients in Wisconsin
Surgeons, Surgical Procedure, Unspecified
RecruitingPhase 4
A Clinical Trial on the Use of Lidocaine Infusion During Surgery for Pediatric Upper Extremity Fractures and Its Impact on Total Perioperative Opioid Requirements
Fracture Arm, Fracture Closed of Lower End of Forearm, Unspecified
Not yet recruitingPhase 4
Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
Minimally Invasive Surgical Procedures, Abnormal Uterine Bleeding, Unspecified
Recruiting
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
Critical Illness, Surgical Procedure, Unspecified
Not yet recruitingObservational study
A Retrospective and Prospective Clinical Registry for Data Collection of Perimenopausal, Menopausal and Premature Ovarian Insufficiency Women
Menopause, Menopausal Hormone Therapy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Surgical Procedure, Unspecified and Intensive Care Units (ICUs), run by Medtronic - MITG at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Collect patient and clinicians' feedback about the CCPC Platform (time frame: From enrollment to the end of follow up at 10 days). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.